keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ezatiostat (TER199(free base)) 是一种谷胱甘肽的三肽类似物,也是一种选择性的口服活性的谷胱甘肽 S-转移酶 P1-1 (GSTP1) 抑制剂。它通过抑制GSTP1导致 JNK 激活,刺激淋巴细胞生成和骨髓祖细胞增殖,可研究骨髓增生异常综合症。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 263 | 现货 | ||
5 mg | ¥ 617 | 现货 | ||
10 mg | ¥ 987 | 现货 | ||
25 mg | ¥ 1,870 | 现货 | ||
50 mg | ¥ 2,930 | 现货 | ||
100 mg | ¥ 4,260 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 719 | 现货 |
产品描述 | Ezatiostat (TER199(free base)) is a tripeptide analog of glutathione that can selectively inhibit GSTP1-1 catalytic activity. |
体内活性 | Ezatiostat was administered to 19 patients with non-deletion(5q) myelodysplastic syndrome (MDS) at one of two doses (2000 mg or 2500 mg/day) in combination with 10 mg of lenalidomide on days 1-21 of a 28-day cycle. One of 4 evaluable patients (25%) in the 2500/10 mg dose group experienced an erythroid hematologic improvement (HI-E) response by 2006 MDS International Working Group (IWG) criteria. Four of 10 evaluable patients (40%) in the 2000 mg/10 mg dose group experienced a HI-E response [1]. Systemic inhibition of GSTP1 with Ezatiostat (0-30 mg/kg, i.p.) dose-dependently reduced the reinforcing effects of alcohol as measured by operant self-administration, in the absence of motor effects [2]. |
别名 | TER199(free base), TLK199 |
分子量 | 529.65 |
分子式 | C27H35N3O6S |
CAS No. | 168682-53-9 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: >50 mg/mL (94.4 mM)
Ethanol: 20 mg/mL (37.76)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.888 mL | 9.4402 mL | 18.8804 mL | 47.201 mL |
5 mM | 0.3776 mL | 1.888 mL | 3.7761 mL | 9.4402 mL | |
10 mM | 0.1888 mL | 0.944 mL | 1.888 mL | 4.7201 mL | |
20 mM | 0.0944 mL | 0.472 mL | 0.944 mL | 2.36 mL | |
50 mM | 0.0378 mL | 0.1888 mL | 0.3776 mL | 0.944 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ezatiostat 168682-53-9 Apoptosis Metabolism oxidation-reduction Glutathione Peroxidase GST Inhibitor lymphocyte inhibit Glutathione transferases TLK 199 GSTs Gutathione S-transferase proliferation c-Jun JNK GSTP1 TLK-199 ERK1 MDS TER199(free base) TLK199 tripeptide inhibitor